Amgen at Antibody Engineering 2026
Dec 13–16, 2026 San Diego, CA ~900 attendees Website
Amgen takes part in 4 sessions at Antibody Engineering 2026 in San Diego. Its program centers on what matters most when taking an antibody from discovery to a first clinical trial filing, and on antibodies that work by induced proximity. It also covers generative AI protein design that is steered toward molecules that are easy to develop and manufacture.
| Organization | Antibody Engineering 2026 Attendance |
|---|---|
Amgen Thousand Oaks, CA | |
Global biopharmaceutical company developing and manufacturing biologic medicines, including bispecific T-cell engagers. | Chair Sun Dec 13 1:00pm–1:15pm Talk Sun Dec 13 1:15pm–1:45pm Developability-Guided Generative Biology for Therapeutic Protein Engineering Designing new therapeutic proteins by computer while checking from the start that they can be made and purified. AI & computational design Talk Sun Dec 13 4:15pm–5:00pm Talk Mon Dec 14 5:45pm–6:15pm Induced Proximity and Next-Generation Antibody Therapeutics Bispecifics & multispecifics |
Find decision makers at Amgen
Tell us what you sell and we’ll find the people at Amgen most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by Antibody Engineering & Therapeutics, its organizers or The Antibody Society. Submit a correction